Multicell Techs Stock Current Liabilities
Multicell Techs fundamentals help investors to digest information that contributes to Multicell Techs' financial success or failures. It also enables traders to predict the movement of Multicell Pink Sheet. The fundamental analysis module provides a way to measure Multicell Techs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Multicell Techs pink sheet.
Multicell |
Multicell Techs Company Current Liabilities Analysis
Multicell Techs' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Multicell Techs Current Liabilities | 1.54 M |
Most of Multicell Techs' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Multicell Techs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Multicell Techs has a Current Liabilities of 1.54 M. This is 99.91% lower than that of the Biotechnology sector and 99.72% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.98% higher than that of the company.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Multicell Fundamentals
| Return On Asset | -1.36 | |||
| Profit Margin | (0.31) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 1.22 M | |||
| Shares Outstanding | 5 B | |||
| Shares Owned By Insiders | 9.90 % | |||
| Price To Sales | 0.01 X | |||
| Revenue | 49.32 K | |||
| Gross Profit | 49.32 K | |||
| Net Income | (380.07 K) | |||
| Cash And Equivalents | 281.12 K | |||
| Total Debt | 36.43 K | |||
| Current Ratio | 0.19 X | |||
| Cash Flow From Operations | (1.09 M) | |||
| Beta | -7.77 | |||
| Market Capitalization | 1 M | |||
| Total Asset | 126.22 K | |||
| Retained Earnings | (50.74 M) | |||
| Working Capital | (1.24 M) | |||
| Current Asset | 295 K | |||
| Current Liabilities | 1.54 M | |||
| Net Asset | 126.22 K |
About Multicell Techs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Multicell Techs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multicell Techs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multicell Techs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Multicell Pink Sheet Analysis
When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.